United States · FDA National Drug Code directory

Hydrochlorothiazide

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
43547-398_d8ce29b2-7f3a-4944-bf9e-0fcebb25d3c4
Product NDC
43547-398
Form
TABLET
Composition / generic term
Hydrochlorothiazide
Labeler
Solco Healthcare U.S., LLC
Marketing category
ANDA
Marketing start / end (source format)
20020329
Source listing expiry
20261231

Source-listed ingredients

  • HYDROCHLOROTHIAZIDE — 50 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 10 TABLET in 1 BOTTLE, PLASTIC (43547-398-01) · 43547-398-01
  • 30 TABLET in 1 BOTTLE, PLASTIC (43547-398-03) · 43547-398-03
  • 50 TABLET in 1 BOTTLE, PLASTIC (43547-398-05) · 43547-398-05
  • 100 TABLET in 1 BOTTLE, PLASTIC (43547-398-10) · 43547-398-10
  • 1000 TABLET in 1 BOTTLE, PLASTIC (43547-398-11) · 43547-398-11
  • 500 TABLET in 1 BOTTLE, PLASTIC (43547-398-50) · 43547-398-50

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →